Kelly Walton
5PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 27, 2026
Targeting Aurora kinase A to prevent GVHD and relapse after myeloablative allogeneic hematopoietic cell transplantation.Shernan G Holtan, Punita Grover, Kelly Walton
|Jul 24, 2024
JAK2/mTOR inhibition fails to prevent acute GVHD despite reduced Th1/Th17 cells: final phase 2 trial results.Joseph Pidala, Shernan G Holtan, Kelly Walton
|Jan 09, 2023
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality.Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton
|Mar 23, 2021
Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results.Joseph Pidala, Kelly Walton, Hany Elmariah
|Aug 23, 2018
Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma.David M Woods, Rupal Ramakrishnan, Andressa S Laino
Pageof 1
Frequent Collaborators
3 joint publications
Marco L Davila
3 joint publications
Bruce R Blazar
3 joint publications
Shernan G Holtan
2 joint publications
Hany Elmariah
2 joint publications
Jongphil Kim
2 joint publications
Brian C Betts
2 joint publications
Daniel J Weisdorf
2 joint publications
Najla El Jurdi
1 joint publications
Nicholas J Lawrence
1 joint publications
Anne A Eaton
